Telavancin: the long and winding road from discovery to food and drug administration approvals and future directions. [electronic resource]
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Sep 2015
- S38-47 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1537-6591
10.1093/cid/civ522 doi
Aminoglycosides--pharmacokinetics Animals Anti-Bacterial Agents--pharmacology Clinical Trials as Topic Disease Models, Animal Drug Approval Drug Discovery Gram-Positive Bacterial Infections--drug therapy Humans Lipoglycopeptides Methicillin-Resistant Staphylococcus aureus--drug effects United States United States Food and Drug Administration--legislation & jurisprudence